Caplacizumab

Drug

About

Thing
Caplacizumab is a bivalent Single-domain antibody designed for the treatment of thrombotic thrombocytopenic purpura and thrombosis. This drug was developed by Ablynx NV.
Caplacizumab
Definition
Caplacizumab is a bivalent Single-domain antibody designed for the treatment of thrombotic thrombocytopenic purpura and thrombosis. This drug was developed by Ablynx NV.
Caplacizumab
Caplacizumab
Caplacizumab is a bivalent Single-domain antibody designed for the treatment of thrombotic thrombocytopenic purpura and thrombosis. This drug was developed by Ablynx NV.
See also: